ARGX - argenx announces results of Annual General Meeting of Shareholders | Benzinga
May 7, 2024 – 5:30pm ET
Amsterdam, the Netherlands – argenx SE ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the results of its Annual General Meeting of shareholders held today.
All items on the agenda received a majority of votes in favor except for agenda item 5 (adoption of the remuneration policy).
As part of the approved resolutions:
- The Company's annual report and annual accounts for the financial year ending December 31, 2023 were approved;
- Dr. Brian L. Kotzin has been appointed as non-executive director to the Board of Directors for a term of four years. Dr. Kotzin brings broad medical and scientific research and development experience to the ...